About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 Comments of the Bureaus of Economics, Consumer Protection and Competition of the Federal Trade Commission: Limits on Payments for Drugs in the Medicaid Program 1 (1986)

handle is hein.usfed/cbecpmed0001 and id is 1 raw text is: BERC-356-P COMMENTS OF THE BUREAUS OF ECONOMICS, CONSUMER PROTECTION AND COMPETITION OF THE FEDERAL TRADE COMMISSION Washington, D.C. 20580 October 20, 1986 Introduction The staff of the Federal Trade Commission (FTC) is pleased to offer comments on the Notice of a Proposed Rule published by the Health Care Financing Administration (HCFA) of the U.S. Department of Health and Human Services.' HCFA requests comments on three alternative systems for determining the maximum level of federal funding for state reimbursement of retail pharmacies for drugs dispensed to Medicaid customers. In fiscal year 1984, Medicaid program expenditures on prescription drugs totalled about $2 billion.2 The FTC has a long-term interest in the development of competition in the prescription drug market, as reflected in a number of FTC studies assessing competitive conditions in that market.3 Further, the FTC and the 1 On the subject of Limits on Payments for Drugs in the Medicaid Program, file code BERC-356-P, 51 F.R. 29,560 (August 19, 1986) (hereafter referred to as the Notice). These comments represent the views of the Bureaus of Economics, Consumer Protection and Competition and do not necessarily reflect the views of the Federal Trade Commission or any individual Commissioner. The Commission, however, has authorized the filing of these comments. Inquiries regarding these comments should be directed to John Woodbury, Bureau of Economics. 2 R. Helms, Statement by the Acting Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Before the House Subcommittee on Health and the Environment (July 15, 1985), p. 2. 3 These studies include R. Bond and D. Lean, Promotion and Product Differentiation in Two Prescription Drug Markets (FTC, February 1977); Bureau of Consumer Protection, FTC, Drug Product Selection (FTC, 1979) (hereafter, BCP); and A. Masson and R. Steiner, Generic Substitution and Prescription Drug Prices (FTC , October 1985) (hereafter, Masson and Steiner).

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most